JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4301
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.32B
| $756K | ﹤0.01% |
11,513
| – | – |
2013 Q4
30 quarters
|
|
4302
Greenlight Captial
GLRE
$480M
| $756K | ﹤0.01% |
82,703
-47,521
| -36% | -$436K |
2017 Q4
14 quarters
|
|
|
BSCL
4303
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
| $756K | ﹤0.01% |
35,808
-6,984
| -16% | -$147K |
2018 Q1
13 quarters
|
|
4304
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$733M
| $752K | ﹤0.01% |
+13,200
| New | +$324K |
2021 Q2
0 quarters
|
|
4305
iShares New York Muni Bond ETF
NYF
$1.47B
| $750K | ﹤0.01% |
12,832
-784
| -6% | -$45.7K |
2015 Q4
22 quarters
|
|
|
RYZ
4306
Ryerson Holding Corp
RYZ
$1.27B
| $750K | ﹤0.01% |
51,411
-30,319
| -37% | -$479K |
2016 Q1
21 quarters
|
|
|
VCRA
4307
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $750K | ﹤0.01% |
18,818
-35,755
| -66% | -$1.31M |
2017 Q4
14 quarters
|
|
4308
CALL
Twilio
TWLO
$46.3B
| $749K | ﹤0.01% |
1,900
| – | – |
2021 Q1
1 quarter
|
|
4309
Bank First Corp
BFC
$1.66B
| $746K | ﹤0.01% |
10,697
-7,408
| -41% | -$529K |
2019 Q1
9 quarters
|
|
4310
HCI Group
HCI
$2.26B
| $746K | ﹤0.01% |
7,509
+1,956
| +35% | +$159K |
2013 Q3
31 quarters
|
|
4311
PUT
Sprouts Farmers Market
SFM
$6.01B
| $746K | ﹤0.01% |
30,000
-410,700
| -93% | -$11M |
2021 Q1
1 quarter
|
|
|
MGIC
4312
DELISTED
Magic Software Enterprises
MGIC
| $743K | ﹤0.01% |
45,787
-11,137
| -20% | -$178K |
2021 Q1
1 quarter
|
|
|
EXTN
4313
DELISTED
Exterran Corporation
EXTN
| $743K | ﹤0.01% |
156,095
+52,103
| +50% | +$223K |
2015 Q4
22 quarters
|
|
4314
Zedge
ZDGE
$45.2M
| $740K | ﹤0.01% |
40,195
+35,095
| +688% | +$491K |
2021 Q1
1 quarter
|
|
|
FARM
4315
DELISTED
Farmer Brothers
FARM
| $739K | ﹤0.01% |
58,209
-21,849
| -27% | -$238K |
2013 Q2
32 quarters
|
|
4316
Alignment Healthcare
ALHC
$1.61B
| $738K | ﹤0.01% |
31,588
-12,819
| -29% | -$312K |
2021 Q1
1 quarter
|
|
|
TEF
4317
DELISTED
Telefonica
TEF
| $735K | ﹤0.01% |
167,634
-101,568
| -38% | -$440K |
2013 Q2
32 quarters
|
|
4318
Kartoon Studios
TOON
$35.5M
| $733K | ﹤0.01% |
+39,862
| New | +$697K |
2021 Q2
0 quarters
|
|
4319
Peoples Bancorp
PEBO
$1.33B
| $731K | ﹤0.01% |
24,653
-29,304
| -54% | -$953K |
2016 Q4
18 quarters
|
|
4320
Recursion Pharmaceuticals
RXRX
$2.18B
| $730K | ﹤0.01% |
+19,992
| New | +$592K |
2021 Q2
0 quarters
|
|
|
CVAC
4321
DELISTED
CureVac
CVAC
| $728K | ﹤0.01% |
9,906
-34,695
| -78% | -$3.47M |
2020 Q4
2 quarters
|
|
4322
Madrigal Pharmaceuticals
MDGL
$11.5B
| $727K | ﹤0.01% |
7,457
+2,016
| +37% | +$239K |
2017 Q3
15 quarters
|
|
4323
PUT
Nektar Therapeutics
NKTR
$1.6B
| $726K | ﹤0.01% |
2,820
| – | – |
2021 Q1
1 quarter
|
|
4324
Sociedad Química y Minera de Chile
SQM
$18.3B
| $726K | ﹤0.01% |
15,342
+6,384
| +71% | +$315K |
2014 Q1
29 quarters
|
|
4325
Vuzix
VUZI
$243M
| $726K | ﹤0.01% |
39,594
+33,594
| +560% | +$678K |
2020 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.